Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adeno-Associated Virus Gene Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Gene Silencing
1.2.3 Gene Replacement
1.2.4 Gene Addition
1.2.5 Gene Editing
1.3 Market by Application
1.3.1 Global Adeno-Associated Virus Gene Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Research Institute
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Adeno-Associated Virus Gene Therapy Market Perspective (2018-2033)
2.2 Global Adeno-Associated Virus Gene Therapy Growth Trends by Region
2.2.1 Adeno-Associated Virus Gene Therapy Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Adeno-Associated Virus Gene Therapy Historic Market Size by Region (2018-2023)
2.2.3 Adeno-Associated Virus Gene Therapy Forecasted Market Size by Region (2024-2033)
2.3 Adeno-Associated Virus Gene Therapy Market Dynamics
2.3.1 Adeno-Associated Virus Gene Therapy Industry Trends
2.3.2 Adeno-Associated Virus Gene Therapy Market Drivers
2.3.3 Adeno-Associated Virus Gene Therapy Market Challenges
2.3.4 Adeno-Associated Virus Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Adeno-Associated Virus Gene Therapy by Players
3.1.1 Global Adeno-Associated Virus Gene Therapy Revenue by Players (2018-2023)
3.1.2 Global Adeno-Associated Virus Gene Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Adeno-Associated Virus Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Adeno-Associated Virus Gene Therapy, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Adeno-Associated Virus Gene Therapy Market Concentration Ratio
3.4.1 Global Adeno-Associated Virus Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adeno-Associated Virus Gene Therapy Revenue in 2022
3.5 Global Key Players of Adeno-Associated Virus Gene Therapy Head office and Area Served
3.6 Global Key Players of Adeno-Associated Virus Gene Therapy, Product and Application
3.7 Global Key Players of Adeno-Associated Virus Gene Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Adeno-Associated Virus Gene Therapy Breakdown Data by Type
4.1 Global Adeno-Associated Virus Gene Therapy Historic Market Size by Type (2018-2023)
4.2 Global Adeno-Associated Virus Gene Therapy Forecasted Market Size by Type (2024-2033)
5 Adeno-Associated Virus Gene Therapy Breakdown Data by Application
5.1 Global Adeno-Associated Virus Gene Therapy Historic Market Size by Application (2018-2023)
5.2 Global Adeno-Associated Virus Gene Therapy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Adeno-Associated Virus Gene Therapy Market Size (2018-2033)
6.2 North America Adeno-Associated Virus Gene Therapy Market Size by Type
6.2.1 North America Adeno-Associated Virus Gene Therapy Market Size by Type (2018-2023)
6.2.2 North America Adeno-Associated Virus Gene Therapy Market Size by Type (2024-2033)
6.2.3 North America Adeno-Associated Virus Gene Therapy Market Share by Type (2018-2033)
6.3 North America Adeno-Associated Virus Gene Therapy Market Size by Application
6.3.1 North America Adeno-Associated Virus Gene Therapy Market Size by Application (2018-2023)
6.3.2 North America Adeno-Associated Virus Gene Therapy Market Size by Application (2024-2033)
6.3.3 North America Adeno-Associated Virus Gene Therapy Market Share by Application (2018-2033)
6.4 North America Adeno-Associated Virus Gene Therapy Market Size by Country
6.4.1 North America Adeno-Associated Virus Gene Therapy Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Adeno-Associated Virus Gene Therapy Market Size by Country (2018-2023)
6.4.3 North America Adeno-Associated Virus Gene Therapy Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Adeno-Associated Virus Gene Therapy Market Size (2018-2033)
7.2 Europe Adeno-Associated Virus Gene Therapy Market Size by Type
7.2.1 Europe Adeno-Associated Virus Gene Therapy Market Size by Type (2018-2023)
7.2.2 Europe Adeno-Associated Virus Gene Therapy Market Size by Type (2024-2033)
7.2.3 Europe Adeno-Associated Virus Gene Therapy Market Share by Type (2018-2033)
7.3 Europe Adeno-Associated Virus Gene Therapy Market Size by Application
7.3.1 Europe Adeno-Associated Virus Gene Therapy Market Size by Application (2018-2023)
7.3.2 Europe Adeno-Associated Virus Gene Therapy Market Size by Application (2024-2033)
7.3.3 Europe Adeno-Associated Virus Gene Therapy Market Share by Application (2018-2033)
7.4 Europe Adeno-Associated Virus Gene Therapy Market Size by Country
7.4.1 Europe Adeno-Associated Virus Gene Therapy Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Adeno-Associated Virus Gene Therapy Market Size by Country (2018-2023)
7.4.3 Europe Adeno-Associated Virus Gene Therapy Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Adeno-Associated Virus Gene Therapy Market Size (2018-2033)
8.2 China Adeno-Associated Virus Gene Therapy Market Size by Type
8.2.1 China Adeno-Associated Virus Gene Therapy Market Size by Type (2018-2023)
8.2.2 China Adeno-Associated Virus Gene Therapy Market Size by Type (2024-2033)
8.2.3 China Adeno-Associated Virus Gene Therapy Market Share by Type (2018-2033)
8.3 China Adeno-Associated Virus Gene Therapy Market Size by Application
8.3.1 China Adeno-Associated Virus Gene Therapy Market Size by Application (2018-2023)
8.3.2 China Adeno-Associated Virus Gene Therapy Market Size by Application (2024-2033)
8.3.3 China Adeno-Associated Virus Gene Therapy Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Adeno-Associated Virus Gene Therapy Market Size (2018-2033)
9.2 Asia Adeno-Associated Virus Gene Therapy Market Size by Type
9.2.1 Asia Adeno-Associated Virus Gene Therapy Market Size by Type (2018-2023)
9.2.2 Asia Adeno-Associated Virus Gene Therapy Market Size by Type (2024-2033)
9.2.3 Asia Adeno-Associated Virus Gene Therapy Market Share by Type (2018-2033)
9.3 Asia Adeno-Associated Virus Gene Therapy Market Size by Application
9.3.1 Asia Adeno-Associated Virus Gene Therapy Market Size by Application (2018-2023)
9.3.2 Asia Adeno-Associated Virus Gene Therapy Market Size by Application (2024-2033)
9.3.3 Asia Adeno-Associated Virus Gene Therapy Market Share by Application (2018-2033)
9.4 Asia Adeno-Associated Virus Gene Therapy Market Size by Region
9.4.1 Asia Adeno-Associated Virus Gene Therapy Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Adeno-Associated Virus Gene Therapy Market Size by Region (2018-2023)
9.4.3 Asia Adeno-Associated Virus Gene Therapy Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Adeno-Associated Virus Gene Therapy Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Adeno-Associated Virus Gene Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Adeno-Associated Virus Gene Therapy Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Adeno-Associated Virus Gene Therapy Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Adeno-Associated Virus Gene Therapy Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Adeno-Associated Virus Gene Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Adeno-Associated Virus Gene Therapy Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Adeno-Associated Virus Gene Therapy Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Adeno-Associated Virus Gene Therapy Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Adeno-Associated Virus Gene Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Adeno-Associated Virus Gene Therapy Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Adeno-Associated Virus Gene Therapy Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Adeno-Associated Virus Gene Therapy Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Creative Biolabs
11.1.1 Creative Biolabs Company Details
11.1.2 Creative Biolabs Business Overview
11.1.3 Creative Biolabs Adeno-Associated Virus Gene Therapy Introduction
11.1.4 Creative Biolabs Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023)
11.1.5 Creative Biolabs Recent Developments
11.2 Affinia Therapeutics
11.2.1 Affinia Therapeutics Company Details
11.2.2 Affinia Therapeutics Business Overview
11.2.3 Affinia Therapeutics Adeno-Associated Virus Gene Therapy Introduction
11.2.4 Affinia Therapeutics Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023)
11.2.5 Affinia Therapeutics Recent Developments
11.3 Spark Therapeutics
11.3.1 Spark Therapeutics Company Details
11.3.2 Spark Therapeutics Business Overview
11.3.3 Spark Therapeutics Adeno-Associated Virus Gene Therapy Introduction
11.3.4 Spark Therapeutics Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023)
11.3.5 Spark Therapeutics Recent Developments
11.4 AGC Biologics
11.4.1 AGC Biologics Company Details
11.4.2 AGC Biologics Business Overview
11.4.3 AGC Biologics Adeno-Associated Virus Gene Therapy Introduction
11.4.4 AGC Biologics Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023)
11.4.5 AGC Biologics Recent Developments
11.5 StrideBio
11.5.1 StrideBio Company Details
11.5.2 StrideBio Business Overview
11.5.3 StrideBio Adeno-Associated Virus Gene Therapy Introduction
11.5.4 StrideBio Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023)
11.5.5 StrideBio Recent Developments
11.6 SIRION Biotech
11.6.1 SIRION Biotech Company Details
11.6.2 SIRION Biotech Business Overview
11.6.3 SIRION Biotech Adeno-Associated Virus Gene Therapy Introduction
11.6.4 SIRION Biotech Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023)
11.6.5 SIRION Biotech Recent Developments
11.7 Neurophth Biotechnology
11.7.1 Neurophth Biotechnology Company Details
11.7.2 Neurophth Biotechnology Business Overview
11.7.3 Neurophth Biotechnology Adeno-Associated Virus Gene Therapy Introduction
11.7.4 Neurophth Biotechnology Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023)
11.7.5 Neurophth Biotechnology Recent Developments
11.8 Belief BioMed
11.8.1 Belief BioMed Company Details
11.8.2 Belief BioMed Business Overview
11.8.3 Belief BioMed Adeno-Associated Virus Gene Therapy Introduction
11.8.4 Belief BioMed Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023)
11.8.5 Belief BioMed Recent Developments
11.9 BiBo Biopharma Engineering Co., Ltd.
11.9.1 BiBo Biopharma Engineering Co., Ltd. Company Details
11.9.2 BiBo Biopharma Engineering Co., Ltd. Business Overview
11.9.3 BiBo Biopharma Engineering Co., Ltd. Adeno-Associated Virus Gene Therapy Introduction
11.9.4 BiBo Biopharma Engineering Co., Ltd. Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023)
11.9.5 BiBo Biopharma Engineering Co., Ltd. Recent Developments
11.10 Beihai Kangcheng
11.10.1 Beihai Kangcheng Company Details
11.10.2 Beihai Kangcheng Business Overview
11.10.3 Beihai Kangcheng Adeno-Associated Virus Gene Therapy Introduction
11.10.4 Beihai Kangcheng Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023)
11.10.5 Beihai Kangcheng Recent Developments
11.11 PackGene Biotech
11.11.1 PackGene Biotech Company Details
11.11.2 PackGene Biotech Business Overview
11.11.3 PackGene Biotech Adeno-Associated Virus Gene Therapy Introduction
11.11.4 PackGene Biotech Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023)
11.11.5 PackGene Biotech Recent Developments
11.12 Sarepta Therapeutics
11.12.1 Sarepta Therapeutics Company Details
11.12.2 Sarepta Therapeutics Business Overview
11.12.3 Sarepta Therapeutics Adeno-Associated Virus Gene Therapy Introduction
11.12.4 Sarepta Therapeutics Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023)
11.12.5 Sarepta Therapeutics Recent Developments
11.13 Carbon BioSciences
11.13.1 Carbon BioSciences Company Details
11.13.2 Carbon BioSciences Business Overview
11.13.3 Carbon BioSciences Adeno-Associated Virus Gene Therapy Introduction
11.13.4 Carbon BioSciences Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023)
11.13.5 Carbon BioSciences Recent Developments
11.14 Kelonia Therapeutics
11.14.1 Kelonia Therapeutics Company Details
11.14.2 Kelonia Therapeutics Business Overview
11.14.3 Kelonia Therapeutics Adeno-Associated Virus Gene Therapy Introduction
11.14.4 Kelonia Therapeutics Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023)
11.14.5 Kelonia Therapeutics Recent Developments
11.15 Roche
11.15.1 Roche Company Details
11.15.2 Roche Business Overview
11.15.3 Roche Adeno-Associated Virus Gene Therapy Introduction
11.15.4 Roche Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023)
11.15.5 Roche Recent Developments
11.16 Remedium Bio
11.16.1 Remedium Bio Company Details
11.16.2 Remedium Bio Business Overview
11.16.3 Remedium Bio Adeno-Associated Virus Gene Therapy Introduction
11.16.4 Remedium Bio Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023)
11.16.5 Remedium Bio Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Adeno-Associated Virus Gene Therapy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Gene Silencing
Table 3. Key Players of Gene Replacement
Table 4. Key Players of Gene Addition
Table 5. Key Players of Gene Editing
Table 6. Global Adeno-Associated Virus Gene Therapy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 7. Global Adeno-Associated Virus Gene Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Adeno-Associated Virus Gene Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Adeno-Associated Virus Gene Therapy Market Share by Region (2018-2023)
Table 10. Global Adeno-Associated Virus Gene Therapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Adeno-Associated Virus Gene Therapy Market Share by Region (2024-2033)
Table 12. Adeno-Associated Virus Gene Therapy Market Trends
Table 13. Adeno-Associated Virus Gene Therapy Market Drivers
Table 14. Adeno-Associated Virus Gene Therapy Market Challenges
Table 15. Adeno-Associated Virus Gene Therapy Market Restraints
Table 16. Global Adeno-Associated Virus Gene Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Adeno-Associated Virus Gene Therapy Revenue Share by Players (2018-2023)
Table 18. Global Top Adeno-Associated Virus Gene Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adeno-Associated Virus Gene Therapy as of 2022)
Table 19. Global Adeno-Associated Virus Gene Therapy Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by Adeno-Associated Virus Gene Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of Adeno-Associated Virus Gene Therapy, Headquarters and Area Served
Table 22. Global Key Players of Adeno-Associated Virus Gene Therapy, Product and Application
Table 23. Global Key Players of Adeno-Associated Virus Gene Therapy, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Adeno-Associated Virus Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Adeno-Associated Virus Gene Therapy Revenue Market Share by Type (2018-2023)
Table 27. Global Adeno-Associated Virus Gene Therapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Adeno-Associated Virus Gene Therapy Revenue Market Share by Type (2024-2033)
Table 29. Global Adeno-Associated Virus Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Adeno-Associated Virus Gene Therapy Revenue Share by Application (2018-2023)
Table 31. Global Adeno-Associated Virus Gene Therapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Adeno-Associated Virus Gene Therapy Revenue Share by Application (2024-2033)
Table 33. North America Adeno-Associated Virus Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America Adeno-Associated Virus Gene Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 35. North America Adeno-Associated Virus Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America Adeno-Associated Virus Gene Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 37. North America Adeno-Associated Virus Gene Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. North America Adeno-Associated Virus Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Adeno-Associated Virus Gene Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 40. Europe Adeno-Associated Virus Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe Adeno-Associated Virus Gene Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 42. Europe Adeno-Associated Virus Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe Adeno-Associated Virus Gene Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 44. Europe Adeno-Associated Virus Gene Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Europe Adeno-Associated Virus Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe Adeno-Associated Virus Gene Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 47. China Adeno-Associated Virus Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 48. China Adeno-Associated Virus Gene Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 49. China Adeno-Associated Virus Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 50. China Adeno-Associated Virus Gene Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 51. Asia Adeno-Associated Virus Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia Adeno-Associated Virus Gene Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 53. Asia Adeno-Associated Virus Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia Adeno-Associated Virus Gene Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 55. Asia Adeno-Associated Virus Gene Therapy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 56. Asia Adeno-Associated Virus Gene Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia Adeno-Associated Virus Gene Therapy Market Size by Region (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Adeno-Associated Virus Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Adeno-Associated Virus Gene Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Adeno-Associated Virus Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Adeno-Associated Virus Gene Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Adeno-Associated Virus Gene Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 63. Middle East, Africa, and Latin America Adeno-Associated Virus Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Adeno-Associated Virus Gene Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 65. Creative Biolabs Company Details
Table 66. Creative Biolabs Business Overview
Table 67. Creative Biolabs Adeno-Associated Virus Gene Therapy Product
Table 68. Creative Biolabs Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023) & (US$ Million)
Table 69. Creative Biolabs Recent Developments
Table 70. Affinia Therapeutics Company Details
Table 71. Affinia Therapeutics Business Overview
Table 72. Affinia Therapeutics Adeno-Associated Virus Gene Therapy Product
Table 73. Affinia Therapeutics Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023) & (US$ Million)
Table 74. Affinia Therapeutics Recent Developments
Table 75. Spark Therapeutics Company Details
Table 76. Spark Therapeutics Business Overview
Table 77. Spark Therapeutics Adeno-Associated Virus Gene Therapy Product
Table 78. Spark Therapeutics Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023) & (US$ Million)
Table 79. Spark Therapeutics Recent Developments
Table 80. AGC Biologics Company Details
Table 81. AGC Biologics Business Overview
Table 82. AGC Biologics Adeno-Associated Virus Gene Therapy Product
Table 83. AGC Biologics Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023) & (US$ Million)
Table 84. AGC Biologics Recent Developments
Table 85. StrideBio Company Details
Table 86. StrideBio Business Overview
Table 87. StrideBio Adeno-Associated Virus Gene Therapy Product
Table 88. StrideBio Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023) & (US$ Million)
Table 89. StrideBio Recent Developments
Table 90. SIRION Biotech Company Details
Table 91. SIRION Biotech Business Overview
Table 92. SIRION Biotech Adeno-Associated Virus Gene Therapy Product
Table 93. SIRION Biotech Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023) & (US$ Million)
Table 94. SIRION Biotech Recent Developments
Table 95. Neurophth Biotechnology Company Details
Table 96. Neurophth Biotechnology Business Overview
Table 97. Neurophth Biotechnology Adeno-Associated Virus Gene Therapy Product
Table 98. Neurophth Biotechnology Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023) & (US$ Million)
Table 99. Neurophth Biotechnology Recent Developments
Table 100. Belief BioMed Company Details
Table 101. Belief BioMed Business Overview
Table 102. Belief BioMed Adeno-Associated Virus Gene Therapy Product
Table 103. Belief BioMed Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023) & (US$ Million)
Table 104. Belief BioMed Recent Developments
Table 105. BiBo Biopharma Engineering Co., Ltd. Company Details
Table 106. BiBo Biopharma Engineering Co., Ltd. Business Overview
Table 107. BiBo Biopharma Engineering Co., Ltd. Adeno-Associated Virus Gene Therapy Product
Table 108. BiBo Biopharma Engineering Co., Ltd. Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023) & (US$ Million)
Table 109. BiBo Biopharma Engineering Co., Ltd. Recent Developments
Table 110. Beihai Kangcheng Company Details
Table 111. Beihai Kangcheng Business Overview
Table 112. Beihai Kangcheng Adeno-Associated Virus Gene Therapy Product
Table 113. Beihai Kangcheng Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023) & (US$ Million)
Table 114. Beihai Kangcheng Recent Developments
Table 115. PackGene Biotech Company Details
Table 116. PackGene Biotech Business Overview
Table 117. PackGene Biotech Adeno-Associated Virus Gene Therapy Product
Table 118. PackGene Biotech Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023) & (US$ Million)
Table 119. PackGene Biotech Recent Developments
Table 120. Sarepta Therapeutics Company Details
Table 121. Sarepta Therapeutics Business Overview
Table 122. Sarepta Therapeutics Adeno-Associated Virus Gene Therapy Product
Table 123. Sarepta Therapeutics Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023) & (US$ Million)
Table 124. Sarepta Therapeutics Recent Developments
Table 125. Carbon BioSciences Company Details
Table 126. Carbon BioSciences Business Overview
Table 127. Carbon BioSciences Adeno-Associated Virus Gene Therapy Product
Table 128. Carbon BioSciences Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023) & (US$ Million)
Table 129. Carbon BioSciences Recent Developments
Table 130. Kelonia Therapeutics Company Details
Table 131. Kelonia Therapeutics Business Overview
Table 132. Kelonia Therapeutics Adeno-Associated Virus Gene Therapy Product
Table 133. Kelonia Therapeutics Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023) & (US$ Million)
Table 134. Kelonia Therapeutics Recent Developments
Table 135. Roche Company Details
Table 136. Roche Business Overview
Table 137. Roche Adeno-Associated Virus Gene Therapy Product
Table 138. Roche Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023) & (US$ Million)
Table 139. Roche Recent Developments
Table 140. Remedium Bio Company Details
Table 141. Remedium Bio Business Overview
Table 142. Remedium Bio Adeno-Associated Virus Gene Therapy Product
Table 143. Remedium Bio Revenue in Adeno-Associated Virus Gene Therapy Business (2018-2023) & (US$ Million)
Table 144. Remedium Bio Recent Developments
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adeno-Associated Virus Gene Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Adeno-Associated Virus Gene Therapy Market Share by Type: 2022 VS 2033
Figure 3. Gene Silencing Features
Figure 4. Gene Replacement Features
Figure 5. Gene Addition Features
Figure 6. Gene Editing Features
Figure 7. Global Adeno-Associated Virus Gene Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 8. Global Adeno-Associated Virus Gene Therapy Market Share by Application: 2022 VS 2033
Figure 9. Hospitals Case Studies
Figure 10. Research Institute Case Studies
Figure 11. Others Case Studies
Figure 12. Adeno-Associated Virus Gene Therapy Report Years Considered
Figure 13. Global Adeno-Associated Virus Gene Therapy Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Adeno-Associated Virus Gene Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Adeno-Associated Virus Gene Therapy Market Share by Region: 2022 VS 2033
Figure 16. Global Adeno-Associated Virus Gene Therapy Market Share by Players in 2022
Figure 17. Global Top Adeno-Associated Virus Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adeno-Associated Virus Gene Therapy as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Adeno-Associated Virus Gene Therapy Revenue in 2022
Figure 19. North America Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Adeno-Associated Virus Gene Therapy Market Share by Type (2018-2033)
Figure 21. North America Adeno-Associated Virus Gene Therapy Market Share by Application (2018-2033)
Figure 22. North America Adeno-Associated Virus Gene Therapy Market Share by Country (2018-2033)
Figure 23. United States Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Adeno-Associated Virus Gene Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 26. Europe Adeno-Associated Virus Gene Therapy Market Share by Type (2018-2033)
Figure 27. Europe Adeno-Associated Virus Gene Therapy Market Share by Application (2018-2033)
Figure 28. Europe Adeno-Associated Virus Gene Therapy Market Share by Country (2018-2033)
Figure 29. Germany Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. France Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. U.K. Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Italy Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Russia Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Nordic Countries Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. China Adeno-Associated Virus Gene Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 36. China Adeno-Associated Virus Gene Therapy Market Share by Type (2018-2033)
Figure 37. China Adeno-Associated Virus Gene Therapy Market Share by Application (2018-2033)
Figure 38. Asia Adeno-Associated Virus Gene Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 39. Asia Adeno-Associated Virus Gene Therapy Market Share by Type (2018-2033)
Figure 40. Asia Adeno-Associated Virus Gene Therapy Market Share by Application (2018-2033)
Figure 41. Asia Adeno-Associated Virus Gene Therapy Market Share by Region (2018-2033)
Figure 42. Japan Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. South Korea Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. China Taiwan Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Southeast Asia Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. India Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Australia Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Adeno-Associated Virus Gene Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Adeno-Associated Virus Gene Therapy Market Share by Type (2018-2033)
Figure 50. Middle East, Africa, and Latin America Adeno-Associated Virus Gene Therapy Market Share by Application (2018-2033)
Figure 51. Middle East, Africa, and Latin America Adeno-Associated Virus Gene Therapy Market Share by Country (2018-2033)
Figure 52. Brazil Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Mexico Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Turkey Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Saudi Arabia Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Israel Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. GCC Countries Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Creative Biolabs Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2018-2023)
Figure 59. Affinia Therapeutics Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2018-2023)
Figure 60. Spark Therapeutics Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2018-2023)
Figure 61. AGC Biologics Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2018-2023)
Figure 62. StrideBio Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2018-2023)
Figure 63. SIRION Biotech Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2018-2023)
Figure 64. Neurophth Biotechnology Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2018-2023)
Figure 65. Belief BioMed Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2018-2023)
Figure 66. BiBo Biopharma Engineering Co., Ltd. Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2018-2023)
Figure 67. Beihai Kangcheng Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2018-2023)
Figure 68. PackGene Biotech Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2018-2023)
Figure 69. Sarepta Therapeutics Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2018-2023)
Figure 70. Carbon BioSciences Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2018-2023)
Figure 71. Kelonia Therapeutics Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2018-2023)
Figure 72. Roche Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2018-2023)
Figure 73. Remedium Bio Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2018-2023)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed